Below the Belt Research Fund - SUBDUE – 1 SUB-urothelial DUrvalumab InjEction - 1

Project Details

StatusFinished
Effective start/end date1/07/1930/06/21

Funding

  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group: AUD25,137.00
  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group: AUD24,863.00
  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group